Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.

[1]  H. Kuroda,et al.  GST-pi gene-transduced hematopoietic progenitor cell transplantation overcomes the bone marrow toxicity of cyclophosphamide in mice. , 2000, Human gene therapy.

[2]  M. Pincus,et al.  Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase. , 2000, Annals of clinical and laboratory science.

[3]  P. Nowell,et al.  Association of CYP3A4 genotype with treatment-related leukemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Bell,et al.  Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. , 1998, Journal of the National Cancer Institute.

[5]  S. Langabeer,et al.  Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia , 1997, The Lancet.

[6]  J. Boultwood,et al.  Glutathione S-transferase gene deletions in myelodysplasia , 1997, The Lancet.

[7]  J. Karp,et al.  The molecular pathogenesis of treatment-induced (secondary) leukemias: foundations for treatment and prevention. , 1997, Seminars in oncology.

[8]  S. Ben-Neriah,et al.  Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. , 1996, Blood.

[9]  T. Takayama,et al.  Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. , 1996, Cancer research.

[10]  C. Bloomfield,et al.  Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect , 1996, The Lancet.

[11]  T. Buchner.  AKUTE MYELOISCHE LEUKAMIE , 1996 .

[12]  K. Golka,et al.  Comparative genotyping and phenotyping of glutathione S-transferase GSTT1 , 1996, Archives of Toxicology.

[13]  W. Hiddemann,et al.  Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations , 1995 .

[14]  E. Bowman,et al.  Human Lung Carcinogen—DNA Adduct Levels Mediated by Genetic Polymorphisms In Vivo , 1995 .

[15]  J. Hayes,et al.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.

[16]  H. Bolt,et al.  Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. , 1994, The Biochemical journal.

[17]  D. Waxman,et al.  Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. , 1994, Biochemical pharmacology.

[18]  N K Spurr,et al.  Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. , 1993, Carcinogenesis.

[19]  Jack A. Taylor,et al.  Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. , 1993, Journal of the National Cancer Institute.

[20]  A. Harris,et al.  Reduced topoisomerase II and elevated alpha class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C. , 1992, Biochemical pharmacology.

[21]  C. Bloomfield,et al.  Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. , 1992, Seminars in oncology.

[22]  R. Pero,et al.  Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. , 1990, Carcinogenesis.

[23]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[24]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[25]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.